首页|甲巯咪唑片联合普萘洛尔治疗甲状腺功能亢进的临床疗效

甲巯咪唑片联合普萘洛尔治疗甲状腺功能亢进的临床疗效

扫码查看
目的 探究甲巯咪唑片联合普萘洛尔治疗甲状腺功能亢进(甲亢)的临床疗效。方法 选择 2020 年 9 月至2022 年 9 月期间在义马煤业集团股份有限公司总医院治疗的 102 例甲亢患者,应用随机数表法将其分为对照组(甲巯咪唑片)及观察组(甲巯咪唑片联合普萘洛尔)各 51 例,比较两组治疗有效率、甲状腺功能、炎症因子、脂质代谢指标、不良反应发生率。结果 观察组治疗有效率高于对照组,差异具有统计学意义(P<0。05)。治疗后,两组促甲状腺激素(TSH)较治疗前升高、促甲状腺激素受体抗体(TRAb)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)较治疗前降低,差异具有统计学意义(P<0。05);治疗后,观察组TSH高于对照组,TRAb、FT3、FT4 低于对照组,差异具有统计学意义(P<0。05)。治疗后,两组白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)、转化生长因子-β1(TGF-β1)较治疗前降低,差异具有统计学意义(P<0。05);治疗后观察组IL-8、TNF-α、TGF-β1 低于对照组,差异具有统计学意义(P<0。05)。治疗后,两组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)较治疗前升高,差异具有统计学意义(P<0。05);治疗后观察组TC、TG、HDL、LDL高于对照组,差异具有统计学意义(P<0。05)。对照组不良反应发生率高于观察组,差异具有统计学意义(P<0。05)。结论 甲亢患者采用甲巯咪唑片联合普萘洛尔治疗疗效显著,可改善甲状腺功能,提高血脂水平,减轻炎症反应,降低不良反应发生率。
Clinical Efficacy of Methimazole Tablets Combined with Propranolol in the Treatment of Hyperthyroidism
Objective To explore the clinical efficacy of methimazole tablets combined with propranolol in the treatment of hyperthyroidism.Methods From September 2020 to September 2022,102 patients with hyperthyroidism treated in the General Hospital of Yima Coal Industry Group Co.,Ltd.were selected.They were divided into a control group(methimazole tablets)and an observation group(methimazole tablets combined with propranolol)with 51 cases each using a random number table method.The treatment effectiveness,thyroid function,inflammatory factors,lipid metabolism indicators,and adverse reaction incidence rate of the two groups were compared.Results The treatment effectiveness rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the thyroid-stimulating hormone(TSH)of both groups increased compared to those before treatment,and the thyroid-stimulating hormone receptor antibody(TRAb),free triiodothyronine(FT3),and free thyroxine(FT4)decreased compared to those before treatment,and the difference was statistically significant(P<0.05);after treatment,the TSH of the observation group was higher than that of the control group,and TRAb,FT3,and FT4 were lower than those of the control group,and the difference was statistically significant(P<0.05).After treatment,the interleukin-8(IL-8),tumor necrosis factor-α(TNF-α),and transforming growth factor-β1(TGF-β1)of both groups decreased compared to those before treatment,and the difference was statistically significant(P<0.05);after treatment,the IL-8,TNF-α,and TGF-β1 of the observation group were lower than those of the control group,and the difference was statistically significant(P<0.05).After treatment,the total cholesterol(TC),triglycerides(TG),high-density lipoprotein cholesterol(HDL-C),and low-density lipoprotein cholesterol(LDL-C)of both groups increased compared to those before treatment,and the difference was statistically significant(P<0.05);after treatment,the TC,TG,HDL,and LDL of the observation group were higher than those of the control group,and the difference was statistically significant(P<0.05).The incidence rate of adverse reactions in the control group was higher than that in the observation group,and the difference was statistically significant(P<0.05).Conclusion The treatment of hyperthyroidism patients with methimazole tablets combined with propranolol has a significant effect,can improve thyroid function,increase blood lipid levels,reduce inflammatory response,and reduce the incidence of adverse reactions.

methimazole tabletspropranololhyperthyroidisminflammatory factorslipid metabolismadverse reactions

谢毅、刘旭辉、张德智

展开 >

义马煤业集团股份有限公司总医院 普通外科,河南 三门峡 472300

甲巯咪唑片 普萘洛尔 甲状腺功能亢进 炎症因子 脂质代谢 不良反应

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(8)